Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198655926> ?p ?o ?g. }
- W3198655926 endingPage "4514" @default.
- W3198655926 startingPage "4514" @default.
- W3198655926 abstract "Trifluridine/tipiracil is currently approved for metastatic colorectal cancer (mCRC) refractory to available therapies. However, there is no consensus on factors that predict treatment outcomes in daily practice. We assessed the early clinical experience with trifluridine/tipiracil in Spain and potential survival markers. This was a retrospective cohort study of mCRC patients who participated in the trifluridine/tipiracil early clinical experience programme in Spain. The primary outcome was overall survival (OS). Associations between OS and patient characteristics were assessed using multivariate Cox regression analyses. A total of 379 patients were included in the study. Trifluridine/tipiracil was administered for a median of 3.0 cycles and discontinued mainly due to disease progression (79.2%). The median OS was 7.9 months, with a 12-month OS rate of 30.5%. Cox analyses revealed that the following variables independently enhanced OS: ≤2 metastatic sites, no liver metastasis, alkaline phosphatase < 300 IU, trifluridine/tipiracil dose reductions, and neutrophil/lymphocyte ratio < 5. Grade ≥ 3 toxicities were reported in 141 (37.2%) patients, including mainly afebrile neutropaenia (23.2%), anaemia (12.1%), and thrombocytopaenia (5.3%). This study supports the real-life efficacy and safety of trifluridine/tipiracil for refractory mCRC and identifies tumour burden, liver metastasis, alkaline phosphatase, dose reductions, and neutrophil/lymphocyte ratio as survival markers." @default.
- W3198655926 created "2021-09-13" @default.
- W3198655926 creator A5000655348 @default.
- W3198655926 creator A5005025032 @default.
- W3198655926 creator A5014098475 @default.
- W3198655926 creator A5017763783 @default.
- W3198655926 creator A5019550516 @default.
- W3198655926 creator A5020624249 @default.
- W3198655926 creator A5028936344 @default.
- W3198655926 creator A5029660520 @default.
- W3198655926 creator A5036309156 @default.
- W3198655926 creator A5045108507 @default.
- W3198655926 creator A5054053039 @default.
- W3198655926 creator A5056328676 @default.
- W3198655926 creator A5058529760 @default.
- W3198655926 creator A5074210261 @default.
- W3198655926 creator A5081664046 @default.
- W3198655926 creator A5090464803 @default.
- W3198655926 date "2021-09-08" @default.
- W3198655926 modified "2023-09-26" @default.
- W3198655926 title "Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study" @default.
- W3198655926 cites W1980850901 @default.
- W3198655926 cites W2019607817 @default.
- W3198655926 cites W2021102443 @default.
- W3198655926 cites W2025641756 @default.
- W3198655926 cites W2045370737 @default.
- W3198655926 cites W2106726143 @default.
- W3198655926 cites W242040007 @default.
- W3198655926 cites W2467206133 @default.
- W3198655926 cites W2470575266 @default.
- W3198655926 cites W2487577029 @default.
- W3198655926 cites W2549807178 @default.
- W3198655926 cites W2771737720 @default.
- W3198655926 cites W2777105315 @default.
- W3198655926 cites W2789605614 @default.
- W3198655926 cites W2802514896 @default.
- W3198655926 cites W2803670008 @default.
- W3198655926 cites W2889052613 @default.
- W3198655926 cites W2889646458 @default.
- W3198655926 cites W2892085083 @default.
- W3198655926 cites W2937226633 @default.
- W3198655926 cites W2944159393 @default.
- W3198655926 cites W2949229297 @default.
- W3198655926 cites W2954692260 @default.
- W3198655926 cites W2964996229 @default.
- W3198655926 cites W2994974425 @default.
- W3198655926 cites W2999325656 @default.
- W3198655926 cites W3079866290 @default.
- W3198655926 doi "https://doi.org/10.3390/cancers13184514" @default.
- W3198655926 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8468101" @default.
- W3198655926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572740" @default.
- W3198655926 hasPublicationYear "2021" @default.
- W3198655926 type Work @default.
- W3198655926 sameAs 3198655926 @default.
- W3198655926 citedByCount "6" @default.
- W3198655926 countsByYear W31986559262021 @default.
- W3198655926 countsByYear W31986559262023 @default.
- W3198655926 crossrefType "journal-article" @default.
- W3198655926 hasAuthorship W3198655926A5000655348 @default.
- W3198655926 hasAuthorship W3198655926A5005025032 @default.
- W3198655926 hasAuthorship W3198655926A5014098475 @default.
- W3198655926 hasAuthorship W3198655926A5017763783 @default.
- W3198655926 hasAuthorship W3198655926A5019550516 @default.
- W3198655926 hasAuthorship W3198655926A5020624249 @default.
- W3198655926 hasAuthorship W3198655926A5028936344 @default.
- W3198655926 hasAuthorship W3198655926A5029660520 @default.
- W3198655926 hasAuthorship W3198655926A5036309156 @default.
- W3198655926 hasAuthorship W3198655926A5045108507 @default.
- W3198655926 hasAuthorship W3198655926A5054053039 @default.
- W3198655926 hasAuthorship W3198655926A5056328676 @default.
- W3198655926 hasAuthorship W3198655926A5058529760 @default.
- W3198655926 hasAuthorship W3198655926A5074210261 @default.
- W3198655926 hasAuthorship W3198655926A5081664046 @default.
- W3198655926 hasAuthorship W3198655926A5090464803 @default.
- W3198655926 hasBestOaLocation W31986559261 @default.
- W3198655926 hasConcept C121608353 @default.
- W3198655926 hasConcept C126322002 @default.
- W3198655926 hasConcept C143998085 @default.
- W3198655926 hasConcept C50382708 @default.
- W3198655926 hasConcept C526805850 @default.
- W3198655926 hasConcept C71924100 @default.
- W3198655926 hasConcept C90924648 @default.
- W3198655926 hasConceptScore W3198655926C121608353 @default.
- W3198655926 hasConceptScore W3198655926C126322002 @default.
- W3198655926 hasConceptScore W3198655926C143998085 @default.
- W3198655926 hasConceptScore W3198655926C50382708 @default.
- W3198655926 hasConceptScore W3198655926C526805850 @default.
- W3198655926 hasConceptScore W3198655926C71924100 @default.
- W3198655926 hasConceptScore W3198655926C90924648 @default.
- W3198655926 hasIssue "18" @default.
- W3198655926 hasLocation W31986559261 @default.
- W3198655926 hasLocation W31986559262 @default.
- W3198655926 hasLocation W31986559263 @default.
- W3198655926 hasLocation W31986559264 @default.
- W3198655926 hasLocation W31986559265 @default.
- W3198655926 hasOpenAccess W3198655926 @default.
- W3198655926 hasPrimaryLocation W31986559261 @default.
- W3198655926 hasRelatedWork W1964399992 @default.